DOT MEDICAL LTD
UVLrx Therapeutics is dedicated to evidence-based medicine in the field of light therapy and offers the first intravenous, concurrent delivery of ultraviolet-A (UVA) and multiple visible light wavelengths for treating a variety of medical issues. In addition to two Nobel Prizes and NASA-backed research, hundreds of international clinical trials have verified the health benefits of UV and other wavelengths of light utilised in the UVLrxTM Treatment System. UVLrx Intravenous Light Therapy is an essential adjunct therapy. It slows the aging process by reducing chronic inflammation. It accelerates the healing of wounds & lowers the pain associated with aesthetic procedures. It increases stem cell proliferation & survival. For further information, please see UVLrx.com.